How curious minds saved a medicine from being left in the lab

Inspiring the next generation of scientists

Immuno-Oncology: Integrating innovation into standard of care practice

In today’s remarkable field of Immuno-Oncology, there is still much yet to discover.

Building community while celebrating difference through our employee resource groups

Sharing the values of cultural diversity in the workplace

Celebrating our employees and allies #breakingthesilence to make the workplace more inclusive

On May 17, the International Day against Homophobia, Transphobia and Biphobia, we’re celebrating our LGBTQ+ employees and allies.

Meet Risa: The right diagnosis and treatment brought a new outlook

As a third-grade teacher, Risa loves the smiles of her students as they learn new skills or reach a goal. This joy of achievement is an experience Risa appreciates even more because of her journey to diagnosis and effective treatment for a rare disease.

Delivering potentially transformational medicines through R&D innovation in Oncology

Doing our part when disaster hits

It takes a village to save a village

And with 25 million people affected by hurricanes across the nation in just 1 year alone, our partnerships with organizations like Save the Children are critical to helping children when disaster strikes.

Vaccines hold the promise of prevention

Every adult is at risk for infectious diseases, but our chances of warding them off are growing every day.

Our immune system is like a finely tuned orchestra

A few cells out of tune can lead to diseases like asthma and lupus. That’s why immunology is key to our R&D approach.

What happens if antibiotics stop working?

We’re proud to say that we’re one of the few companies still investing in a new generation of antibiotics. Because antibiotic resistance isn’t a problem of the future, it’s already here.

2019 marks our 50 year anniversary...

Can you imagine personalized cancer treatments?

If we map the genetics of a disease...

By identifying the patterns that cause disease, we hope to transform how patients are treated in the future.

Our consumer health Sensory Labs

We combine that understanding with our science to ease the pain people face daily.

COPD is more than a lung disease

Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing, and how it's about treating more than just the lung.

Cancer gets a sting with new discovery

A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.

Vaccines of tomorrow

You, me and 23andMe...

ATS recognizes curious minds...

Steve Yancey and Dr. Hector Ortega were recognized by the American Thoracic Society with its highest award - The Research Innovation and Translation Achievement Award.

Meet Jennifer: a science researcher...

As a biomedical researcher at a major medical institution, Jennifer’s happiest days are spent reading, learning, and working on discovering something that will help improve people’s health. While her research includes rare diseases, she never imagined that she’d one day put her skills to use on herself, to unlock the strange mystery going on inside her body.

Fighting malaria in the lab and on the ground

Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.

A family diagnosis motivates...

As a medical professional, I’m inspired every day to make a difference for COPD patients. As a doctor of pharmacy, I came to GSK motivated by the opportunity to have an impact on patient care.

How do consumer insights fuel our innovation?

Linking a chapter of GSK history to the fight for freedom

Controlled asthma, to me, means freedom

Patients give a voice to living with asthma in this video from GSK and the CHEST Foundation.

If you can’t breathe, you won’t be able to play the tuba

It may seem obvious, but “if you can’t breathe, you’re not going to able to play the tuba very effectively,” said Brendan Bohnhorst, from Grand Rapids, Michigan, USA.

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

What I know about asthma… then and now

Crossing off my bucket list, one breath at a time

Overcoming the challenges of COPD to fulfil a lifelong dream

Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.

Making sense of what consumers want

As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

Breathing life into an idea for a respiratory medicine

Meet Mark Luttmann, one of our respiratory pioneers. Mark was on the drug discovery team for a key component of several of our COPD medications.

I control my asthma, it doesn’t control me

Thank you for calling GSK...

Don’t mind me. I’m just making sure I can breathe.

For some, breathing easy sounds simple – it just happens. But for Sarah and for millions of others like her, breathing can be a daily struggle.

Brian Johns goes boldly for people living with HIV

There are over 36 million people living with HIV around the world with an estimated 70% who are not adequately treating the virus.

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Pricing our medicines to help ensure patient access

We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record.

Helping patients in need

Setting the record straight...

Hunting for energy savings

You never know what you might find when you hunt for waste.

Creating bricks and benches out of medical waste

Instead of being incinerated, medical lab waste at our Upper Providence site is being upcycled into bricks and benches.

Evolving our graduated approach to intellectual property

In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.

On target for a new era of drug discovery?

Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.

Our Science in the Summer program sparks...

Buyer beware: importing drugs comes with big risks

How doctors and insurers get information about medicines

How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?

Living with COPD Every Day: Sean’s Story

Pinch your nose and try breathing through a straw? Not so easy, right?

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?

Inspiring Students through STEM Education Programs

In the next five years, the US will add eight million jobs in STEM fields. Yet more than 20% of all students, and half of all minority students, drop out of school before graduation.

Scientists or detectives? Seeking new clues in COPD

Helping to change the world

Global mission, local impact

We often hear of humanitarian work in other parts of the world, but here in the United States there is real need as well. Around 47 million in the US live in poverty.

In Africa, markets matter for a healthy society

When it comes to improving access to healthcare in Africa, markets matter. From pharmaceutical companies to small clinics, an interconnected private market complements public sector services to help patients receive the healthcare they need, when and where they need it.

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?